In HCC, key enzymes and transporters involved in de novo lipogenesis, fatty acid uptake, and cholesterol synthesis, such as FASN, SCD1, SREBPs, and fatty acid transport proteins, are frequently dysregulated in tumour tissues, contributing to tumour growth, immune evasion and therapy resistance. Here, SCD is linked to hepatocellular carcinoma.